An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

  • A.A. H
  • E. R
  • C.-H. L
  • et al.
ISSN: 1878-3686
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Dysregulated metabolism is a hallmark of cancer, manifested through alterations in metabolites. We performed metabolomic profiling on 138 matched clear cell renal cell carcinoma (ccRCC)/normal tissue pairs and found that ccRCC is characterized by broad shifts in central carbon metabolism, one-carbon metabolism, and antioxidant response. Tumor progression and metastasis were associated with metabolite increases in glutathione and cysteine/methionine metabolism pathways. We develop an analytic pipeline and visualization tool (metabolograms) to bridge the gap between TCGA transcriptomic profiling and our metabolomic data, which enables us to assemble an integrated pathway-level metabolic atlas and to demonstrate discordance between transcriptome and metabolome. Lastly, expression profiling was performed on a high-glutathione cluster, which corresponds to a poor-survival subgroup in the ccRCC TCGA cohort. Using metabolomic profiling, Ari Hakimi et al. show that clear cell renal cell carcinoma is characterized by broad shifts in central carbon metabolism, one-carbon metabolism, and antioxidant response. They also develop metabolograms to allow integrating the TCGA transcriptomic data with their metabolomic data.

Cite

CITATION STYLE

APA

A.A., H., E., R., C.-H., L., C.J., C., A.R., B., A., L., … J.J., H. (2016). An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell, 29(1), 104–116. Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L608524592 http://dx.doi.org/10.1016/j.ccell.2015.12.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free